Advancing Pediatric Drug Development

Diversity and Inclusion

Community Member kudos icon 1 Community member
Briefly describe your research question :

Diversity in clinical trials is imperative to better understand the safety and efficacy profile of novel pediatric therapies and to reduce disparities and advance equal access and opportunities. Yet, the extent to which individuals from minority racial and ethnic groups, across different educational backgrounds, and those with intellectual disabilities and other cognitive impairments are represented in pediatric clinical trials is unknown.

Do ethnicity, age, education, and IQ have an effect on the dropout rate in pediatric clinical trials?

Ensuring that all children have the same chance to join a clinical study and providing the same opportunities for everyone will ensure that the drug is tested across the whole population regardless of race, education or level of functioning.




6 votes
Idea No. 191